ArticleJournal of enzyme inhibition and medicinal chemistry2018

Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and PDGFR-β related to anticancer drug resistance.

Tim Fischer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.